Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Medtronic Receives First FDA Approval of Cobalt Chromium Balloon-Expandable Stent to Treat Narrowed Iliac Arteries

October 31, 2011 By AxoGen, Inc.

MINNEAPOLIS
–– Oct. 31, 2011 –– Advancing the treatment of peripheral artery disease,
Medtronic, Inc. (NYSE: MDT) today announced approval by the U.S. Food and Drug
Administration (FDA) of the Assurant® Cobalt Iliac Balloon-Expandable Stent
System.

The new medical device features the first balloon-expandable
stent made from a cobalt-chromium alloy to be approved by the FDA for the
treatment of narrowed iliac arteries. It complements Medtronics self-expanding
Complete® SE Vascular Stent, which is already approved with an iliac
indication. The iliac arteries branch off the aorta in the abdominal area and
carry blood to downstream vessels that perfuse the pelvis, legs and feet.

The new devices FDA approval was supported by the
nine-month results from the ACTIVE (Use of the Assurant Cobalt Iliac Stent
System in the Treatment of Iliac Vessel Disease) trial, which examined the
outcomes of 123 patients at 17 U.S.
sites.

The Assurant Cobalt stent demonstrated exceptional
technical, procedural and clinical success in the trial and had low rates
of  major adverse events, target lesion revascularization (TLR) and target
vessel revascularization (TVR) –– all at 0.8 percent. In addition, the device
also achieved a 99.2 percent primary patency rate, meaning only one of the 123
study patients required a reintervention through nine months of follow-up.
 

“The Assurant Cobalt stent demonstrated excellent safety and
long-term patency in the prospectively conducted and core lab controlled ACTIVE
trial, with some of the lowest rates of 9-month TLR ever seen in an iliac
interventional trial,” said William A. Gray, M.D., of New York Presbyterian
Hospital and co-principal
investigator of ACTIVE. “The approval of this stent, along with the previous Complete
SE self-expanding stent, significantly adds to the armamentarium for interventionalists,
and therefore benefits our patients.”

The Assurant Cobalt stent leverages the strength of cobalt
chromium and a unique modular design to create a device with ultrathin, round,
edgeless struts, allowing for smooth delivery to iliac artery lesions and
excellent conformability to the vessel wall without sacrificing radial
strength. The combination of these design features enables the stent to be the
only balloon-expandable device to utilize a 6F sheath for the entire size
matrix –– from the smallest (6mm x 20mm) to the largest (10mm x 60mm) size ––
for the treatment of iliac arteries.

In collaboration with leading clinicians, researchers and
scientists worldwide, Medtronic offers the broadest range of innovative medical
technology for the interventional and surgical treatment of cardiovascular
disease and cardiac arrhythmias.

ABOUT MEDTRONIC

Medtronic, Inc. (www.medtronic.com),
headquartered in Minneapolis,
is the global leader in medical technology – alleviating pain, restoring health
and extending life for millions of people around the world.

Related Articles Read More >

A photo of Capstan Medical's mitral valve implant, which uses nitinol.
Capstan Medical’s R&D head discusses the heart valve and robotics startup’s tech, engineering challenges and solutions, advice for others in medtech and how to join his team
An illustration of a neurosurgeon using a robotic endoscope to remove a brain tumor.
MDO Nitinol Innovation Special Report
A photo of Highridge Medical CEO Rebecca Whitney.
Highridge Medical is betting on this spine tech
A photo of the miniature Auxilium Biotechnologies implants made on the International Space Station.
Implants 3D-printed in space could enable nerve regeneration
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe